Ophthalmic Devices Market size is expected to be worth around USD 80.4 Bn by 2033 from USD 50.3 Bn in 2023, growing at a CAGR of 4.8%.

The global ophthalmic devices market size reached USD 28.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.52% during 2025-2033. The market is propelled by the expanding geriatric population, rising prevalence of eye ailments, and the growing medical tourism sector which is driving innovation and investment in advanced eye care technologies.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product type, application, and end use.

The United States Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

Snapshot img

Ophthalmology Devices Market Size 2025-2029

The ophthalmology devices market size is forecast to increase by USD 22.77 billion, at a CAGR of 4.9% between 2024 and 2029.

The market is driven by the escalating prevalence of ophthalmic diseases, fueling the demand for advanced diagnostic and therapeutic devices. This trend is further amplified by the rising medical tourism for affordable ophthalmology surgeries in developing countries, offering cost advantages to patients. However, the market faces significant challenges, including the high cost of ophthalmic devices and limited reimbursement policies, which may hinder market growth for some players.
Companies seeking to capitalize on this market's opportunities must focus on developing cost-effective solutions and navigating reimbursement complexities to maintain a competitive edge. Additionally, investments in research and development to introduce innovative devices and technologies will be crucial for market differentiation and long-term success. Furthermore, the integration of artificial intelligence (AI) in ophthalmology, including retinal imaging analysis and ocular inflammation diagnostics, is revolutionizing disease detection and treatment.

What will be the Size of the Ophthalmology Devices Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

The market continues to evolve, driven by advancements in technology and increasing demand for early disease detection and improved vision correction. Intraocular lenses and laser refractive surgery have revolutionized cataract treatment, leading to a significant increase in surgical success rates. For instance, the number of refractive error corrections performed annually has risen by 15% in the past decade. Ophthalmic viscoelastic devices, optical biometry systems, and optical coherence tomography are essential tools in these applications, providing accurate and detailed imaging for precise diagnosis.
Ocular prosthesis design, glaucoma diagnostic tools, and ophthalmic surgical instruments are other key market segments, benefiting from advancements in materials, such as ocular implant materials, and technologies, like phacoemulsification technology and microincision cataract surgery. Innovations in retinal imaging technology, intravitreal injection systems, and vitreoretinal surgery instruments are further enhancing the market's dynamism. Vision correction technology, such as corneal topography mapping and refractive error correction, is another area of significant growth, with a focus on minimally invasive procedures and personalized treatments.
The integration of artificial intelligence and machine learning algorithms is further driving innovation, enabling more accurate diagnoses and customized treatment plans. In summary, the market is characterized by continuous innovation and growth, with applications spanning early disease detection, vision correction, and surgical interventions. The integration of advanced technologies and materials is transforming diagnostic and therapeutic processes, leading to improved patient outcomes and enhanced quality of care.

How is this Ophthalmology Devices Industry segmented?

The ophthalmology devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Vision care
  Ophthalmology surgical devices
  Ophthalmology diagnostic devices


End-user

  Hospitals and eye clinics
  Academic and research laboratories
  Others


Application

  Cataract surgery
  Diagnosis and monitoring
  Glaucoma treatment
  Vitreo-retinal disorder management
  Refractive error correction


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    Spain
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The Vision care segment is estimated to witness significant growth during the forecast period. Intraocular lenses, a type of lens implanted in the eye during cataract surgery, are experiencing significant advancements, with innovations in materials such as silicone and acrylic. Laser refractive surgery, like LASIK, continues to correct refractive errors without the need for spectacles or contact lenses. Diabetic retinopathy screening, using technologies like optical coherence tomography and automated perimetry systems, is crucial for early detection and treatment. Remote patient monitoring, enabled by teleophthalmology platforms, allows for continuous monitoring of eye health. Ophthalmic viscoelastic devices, used during cataract surgery to maintain the shape of the eye, are essential for successful procedures. Refractive error correction, through methods like phacoemulsification technology and in

The India Ophthalmology Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

The size of the Sweden Ophthalmic Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 4.00% during the forecast period. Recent developments include: In September 2022, Centricity Vision Inc., a global ophthalmic technology company and ZEPTO IOL Positioning System developer launched ZEPTO Plus, a new, innovative addition to its handpiece portfolio., In July 2022, AbbVie and iSTAR Medical SA entered into a strategic partnership to further develop and commercialize iSTAR Medical's MINIject device. It is a minimally invasive glaucoma surgical (MIGS) device for patients with glaucoma.. Key drivers for this market are: Increasing Prevalence of Eye Diseases, Technological Advancements in Ophthalmic Devices. Potential restraints include: Risk Associated with Ophthalmic Procedures and Poor Primary Healthcare Infrastructure. Notable trends are: Contact Lenses Segment is Expected to Witness Growth Over the Forecast Period.

Introduction

The Ophthalmic Devices Market Size is projected to grow significantly, reaching USD 80.4 billion by 2032, up from USD 50.3 billion in 2023. This represents a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2023 to 2032. The market's expansion is fueled by several factors, including an aging population, technological advancements, and increased awareness of eye care.

The growing elderly population has driven demand for ophthalmic devices, as age-related conditions like cataracts and macular degeneration become more common. These devices play a critical role in diagnosing and treating such conditions, thereby enhancing the quality of life for affected individuals. Similarly, chronic diseases like diabetes have increased the prevalence of eye disorders, such as diabetic retinopathy, further boosting demand for advanced ophthalmic solutions.

Technological advancements have also revolutionized the industry. Innovations such as advanced imaging systems and minimally invasive surgical tools have improved the accuracy and effectiveness of eye treatments. These advancements have resulted in better patient outcomes and increased adoption of sophisticated ophthalmic devices globally.

Government initiatives have positively influenced market growth by improving healthcare infrastructure. For instance, in India, ophthalmic devices account for approximately 18% of the total medical devices market, reflecting their growing importance. Additionally, rising awareness about the benefits of regular eye examinations and early disease detection has led to an increased use of diagnostic devices, further driving market growth.

BCC Research Market Report for Ophthalmic Devices. The global market for ophthalmic devices is estimated to increase from $47.5 billion in 2022 to reach $64.2 billion.

Ophthalmic Devices Market size was valued at USD 54.65 Billion in 2024 and is projected to reach USD 73.08 Billion by 2031, growing at a CAGR of 3.7% from 2024 to 2031.

Global Ophthalmic Devices Market Drivers

Aging Population: The demand for ophthalmic devices is driven by the rising prevalence of age-related eye illnesses such cataracts, glaucoma, and macular degeneration brought on by the world's aging population, especially in industrialized nations.

Incidence of Eye problems: The need for corrective and refractive surgery devices is increased by the rising incidence of eye problems, particularly among younger populations, such as myopia, hyperopia, astigmatism, and presbyopia.

Technological Improvements: The effectiveness and safety of eye surgeries and treatments are improved by the rapid improvements in ophthalmic technology, such as laser technology, imaging systems, and minimally invasive surgical procedures. This leads to a boom in the market.

Expenditure on Healthcare: The adoption of modern ophthalmic devices and procedures is supported by rising global healthcare expenditure as well as increased access to healthcare services in emerging economies.

The Brazil Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices (OCT Scanners, and More), Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), and End-User (Hospitals, Specialty Ophthalmic Clinics, Ambulatory Surgery Centers (ASCs), Other End-Users), The Market Forecasts are Provided in Terms of Value (USD).

The size of the India Ophthalmology Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 7.30% during the forecast period. Recent developments include: June 2022: LUMIBIRD opened its new Indian subsidiary in Mumbai: Lumibird Medical India. This company aims to boost the sales of Quantel Medical and Ellex products in India which has a vast range of ultrasound platforms, ophthalmic lasers and equipment for the diagnosis and treatment of dry eye disease., January 2022: Alcon launched the presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology, the AcrySof IQ Vivity IOL (Vivity), in India.. Key drivers for this market are: Growth in Cataract Volume, Technological Advancements in the Field of Ophthalmology; Rising Geriatric Population. Potential restraints include: Shortage of Skilled Professionals, Low Awareness About Eye-related Diseases. Notable trends are: The Glaucoma Surgery Devices Segment is Expected to Hold A Significant Share in the Market Over the Forecast Period.

Ophthalmic Devices Market Outlook

According to our latest research, the global ophthalmic devices market size reached USD 61.2 billion in 2024, reflecting robust demand across both developed and emerging economies. The market is expected to expand at a CAGR of 5.8% from 2025 to 2033, reaching a forecasted value of USD 102.2 billion by 2033. This growth is primarily driven by the rising prevalence of ocular disorders, technological advancements in ophthalmic diagnostics and surgery, and increasing awareness about eye health globally.

A significant growth factor for the ophthalmic devices market is the rapidly increasing prevalence of vision impairment and eye diseases such as cataract, glaucoma, and refractive errors. The World Health Organization estimates that over 2.2 billion people globally suffer from some form of vision impairment, with a substantial proportion requiring medical intervention. This epidemiological trend is further exacerbated by the aging global population, as age is a major risk factor for most chronic eye conditions. As the proportion of elderly individuals rises, particularly in developed regions like North America and Europe, the demand for advanced ophthalmic devices for both diagnosis and treatment is expected to surge, underpinning the market’s long-term expansion.

Another pivotal driver for the ophthalmic devices market is the continuous innovation and integration of advanced technologies. The adoption of digital imaging, artificial intelligence (AI)-powered diagnostic tools, minimally invasive surgical instruments, and smart contact lenses has revolutionized eye care practices. These technologies facilitate early diagnosis, precise treatment, and improved patient outcomes, making them increasingly indispensable in modern ophthalmology. Furthermore, the proliferation of telemedicine and remote monitoring solutions, particularly accelerated by the COVID-19 pandemic, has broadened access to eye care services, fueling the uptake of digital ophthalmic devices in both urban and rural settings.

Additionally, the growing focus on vision care and preventive ophthalmology is positively impacting the ophthalmic devices market. Public and private sector initiatives aimed at raising awareness about the importance of regular eye examinations and early intervention have led to greater patient engagement. The expansion of health insurance coverage for ophthalmic procedures and the inclusion of vision care in government healthcare programs, especially in emerging economies, are also contributing to increased adoption of ophthalmic devices. These trends, combined with rising disposable incomes and lifestyle changes leading to higher incidence of refractive disorders, are expected to sustain market growth over the forecast period.

From a regional perspective, North America continues to dominate the ophthalmic devices market, owing to its advanced healthcare infrastructure, high prevalence of eye diseases, and strong presence of leading industry players. However, the Asia Pacific region is witnessing the fastest growth, driven by large patient populations, rising healthcare investments, and increasing adoption of modern ophthalmic technologies. Europe also holds a significant market share, supported by favorable government policies and a growing elderly population. Meanwhile, Latin America and the Middle East & Africa are emerging as promising markets due to improving healthcare access and rising awareness about eye health.

Product Type Analysis

The ophthalmic devices market by product type is segmented into diagnostic and monitoring devices, surgical devices, and vision care products. Diagnostic and monitoring devices include advanced technologies such as optical coherence tomography (OCT), fundus cameras, and visual field analyzers. These devices are crucial for early detection and ongoing management of ocular diseases, particularly glaucoma and diabetic retinopathy. The increasing prevalence of such chronic conditions, coupled with the growing emphasis on preve

The ophthalmic diagnostic equipment market is expected to grow from USD 3.56 billion in 2025 to USD 5.02 billion by 2035. The market is poised to expand at a 3.5% CAGR during the forecast period.

Ophthalmic Diagnostic Equipment Market Analyzed by Top Investment Segments

Analyzing Top Countries Producing and Distributing Ophthalmic Diagnostic Equipment

According to Cognitive Market Research, the global ophthalmology devices market size is USD 7.0 million in 2024 and will expand at a compound annual growth rate (CAGR) of 4.92% from 2024 to 2031. Market Dynamics of Ophthalmology Devices Market

Key Drivers for Ophthalmology Devices Market

Rise is Cases for Ophthalmic Diseases - Ophthalmic illnesses, including glaucoma and cataracts, are becoming more common, which is a major driver fueling the expansion of the ophthalmology devices market. With the growing need for contact lenses and cutting-edge equipment, these devices are poised to dominate the industry. The market for microinvasive glaucoma surgical implants is expanding at a faster rate than any other treatment. Common eye problems like diabetic retinopathy, cataracts, age-related macular degeneration, and all the other ophthalmic illnesses are expected to fuel market expansion. Rising consumer awareness of ophthalmology devices and an uptick in research and development efforts to create new ones are anticipated to drive the market's expansion.

Key Restraints for Ophthalmology Devices Market

The absence of knowledge on eye-related illnesses is expected to slow down the market's growth. A lack of qualified individuals is expected to pose a problem for the ophthalmology equipment industry. Introduction of the Ophthalmology Devices Market

Ophthalmic devices are medical tools commonly used for diagnosing eye conditions, correcting visual problems, and performing surgeries. Their advantages are becoming more well-known and popular due to the increasing number of people suffering from ophthalmic ailments like glaucoma, cataracts, and others that affect eyesight. The global ophthalmic devices market is expected to experience expansion due to the rising demand for high-quality eye care and the increasing number of procedures meant to correct visual problems. The developing world's improving healthcare infrastructure, along with the rising demand for and demand for less-invasive processes, is anticipated to enhance the expansion of the market.

China Ophthalmic Devices Market Outlook 2031:

The China ophthalmic devices market size was valued at USD 4.51 Billion in 2022 and is projected to reach USD 9.47 Billion by 2031, expanding at a CAGR of 8.59% during the forecast period 2023 - 2031. The growth of the market is attributed to the increasing prevalence of eye disorders and vision loss.

Ophthalmology is known to be a field of clinical science that handles function, structure, and several eye diseases. Ophthalmic devices are clinical instruments that analyze and treat conditions of eyes.

They can be used with an eye-care professional’s supervision, but some can also be self-administered by patients as part of home care. These ranges from simple tonometers to laser surgical systems for correcting eyesight issues such as myopia and hypermetropia, utilized during medical procedures along different items.



At the point when the World Health Organization (WHO) declared Covid-19 as an overall pandemic in March 2020, routine medical care arrangements were kept away to keep patients from getting the infection, and ophthalmology services were especially affected.



Numerous strategies are elective and most patients are older and in risk of experiencing Covid-19 side effects. As the pandemic proceeds with an anticipated ‘third wave,’ ophthalmologists are endeavoring to reduce the backlog of strategies while adhering to safety protocols. The Covid-19 pandemic can prompt a long-term change in the ophthalmology market.

Ophthalmic Devices Market Trends, Drivers, Restraints, and Opportunities

• Growing geriatric population is estimated to accelerate the growth of the market.


• <span style="font-size:11pt

The China ophthalmic devices market is booming, projected to reach $X Billion by 2033, driven by aging demographics and technological advancements. Explore market trends, key players (Alcon, Bausch Health, Johnson & Johnson), and growth opportunities in this comprehensive analysis. Recent developments include: June 2022: Samsara Vision teamed up with Lansheng Medical "MyVision," a China-based ophthalmology company, to create a comprehensive clinical and commercial organization to support Samsara Vision's SING IMTTM (Smaller-Incision New-Generation Implantable Miniature Telescope) in mainland China, Macau, the Hainan Province, and Hong Kong., June 2022: The National Medical Products Administration in China granted Iridex Corporation permission to market and sell its Cyclo G6 platform for the treatment of glaucoma illnesses (NMPA). According to the clearance, Iridex and distribution partners Topcon and Clinico will begin selling the Cyclo G6 system and accompanying probes in China in the third quarter of 2022.. Key drivers for this market are: Increasing Prevalence of Eye Diseases, Technological Advancements in Ophthalmic Devices. Potential restraints include: Increasing Prevalence of Eye Diseases, Technological Advancements in Ophthalmic Devices. Notable trends are: Glaucoma Devices Segment is Expected to Show Better Growth over the Forecast Period.

The Italy Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).

The Germany Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, Ambulatory Surgery Centers (ASCs), and Other End-Users). The Market Forecasts are Provided in Terms of Value (USD).

France Ophthalmic Devices Market Outlook 2031:

The France ophthalmic devices market size was valued at USD 1.33 Billion in 2022 and is likely reach to USD 1.88 Billion by 2031, expanding at a CAGR of 3.89% during the forecast period, 2023-2031. The growth of the market is attributed to the increasing prevalence of eye disorder and vision loss.

Ophthalmology is known to be a field of clinical science that handles function, structure, and several eye diseases. Ophthalmic devices are clinical instruments that assist in analyzing and treating conditions of eyes. They can be used with an eye-care professional’s supervision, but some can also be self-administered by patients.



These range from simple tonometers to advanced diagnostic machines, such as laser surgical systems for correcting eyesight issues such as myopia and hypermetropia. These instruments are utilized during medical procedures along different items.



As per the World Health Organization (WHO), around 2.2 billion individuals can experience ill effects of vision impairment across the globe. The expanding prevalence of ophthalmic disorders such as myopia, diabetic retinopathy, and cataracts is estimated to drive the interest for advanced ophthalmic devices.



At the point when the World Health Organization (WHO) declared Covid-19 as an overall pandemic in March 2020, routine medical care arrangements were kept away to keep patients from getting infection, and ophthalmology services were especially affected. Numerous strategies are elective and most patients are older and in risk of experiencing Covid-19 side effects.



As the pandemic proceeds with an anticipated ‘third wave,’ ophthalmologists are endeavoring to reduce the backlog of strategies while adhering to safety protocols. The Covid-19 pandemic can prompt a long-term change for the market.

Ophthalmic Devices Market Trends, Drivers, Restraints, and Opportunities

• Growing geriatri

Ophthalmic equipment market reaching $111.28B by 2034. Discover breakthrough femtosecond lasers & OCT imaging reshaping diagnostics. Get expert analysis now.